Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
VCAM-1/CD106 Antibody (1.4C3), Alexa Fluor™ 750, Novus Biologicals™

Mouse Monoclonal Antibody
Supplier: Novus Biologicals NBP233182AF750
Description
VCAM-1/CD106 Monoclonal specifically detects VCAM-1/CD106 in Human samples. It is validated for Western Blot, Flow Cytometry, ELISA, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry-Paraffin.Specifications
VCAM-1/CD106 | |
Monoclonal | |
Alexa Fluor 750 | |
50 mM sodium borate with 0.05% sodium azide | |
VCAM1 | |
Stimulated HUVEC cells were used as the immunogen for the VCAM1 (CD106) antibody. | |
0.1 mL | |
7412 | |
Human | |
IgG1 κ |
Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen) | |
1.4C3 | |
Western Blot, ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen | |
CD106, CD106 antigen, DKFZp779G2333, INCAM-100, L1CAM, MGC99561, vascular cell adhesion molecule 1, vascular cell adhesion protein 1, V-CAM 1, VCAM1, VCAM-1 | |
Mouse | |
Protein A or G purified | |
Primary | |
Recognizes a protein of 110kDa, identified as CD106 (also known as vascular cell adhesion molecule-1 (VCAM-1) and INCAM-100). CD106 is a member of the Ig superfamily of adhesion molecules and is expressed at high levels on cytokine stimulated vascular endothelial cells, and at minimal levels on un-stimulated endothelial cells. It is also present on follicular and inter-follicular dendritic cells of lymph nodes, myoblasts, and some macrophages. CD106 serves as a ligand for leukocyte integrin (VLA-4 or CD49d/CD29) and mediates cell adhesion of leukocytes to activated endothelium. It plays a role in various immunological and inflammatory responses. | |
Store at 4°C in the dark. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction